Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 907Genomics and Rare DiseasesGenetic Associations and EpidemiologyGenomics and Phylogenetic Studies

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes

Open access

Abstract

A central challenge in interpreting personal genomes is determining which mutations most likely influence disease. Although progress has been made in scoring the functional impact of individual mutations, the characteristics of the genes in which those mutations are found remain largely unexplored. For example, genes known to carry few common functional variants in healthy individuals may be judged more likely to cause certain kinds of disease than genes known to carry many such variants. Until now, however, it has not been possible to develop a quantitative assessment of how well genes tolerate functional genetic variation on a genome-wide scale. Here we describe an effort that uses sequence data from 6503 whole exome sequences made available by the NHLBI Exome Sequencing Project (ESP). Specifically, we develop an intolerance scoring system that assesses whether genes have relatively more or less functional genetic variation than expected based on the apparently neutral variation found in the gene. To illustrate the utility of this intolerance score, we show that genes responsible for Mendelian diseases are significantly more intolerant to functional genetic variation than genes that do not cause any known disease, but with striking variation in intolerance among genes causing different classes of genetic disease. We conclude by showing that use of an intolerance ranking system can aid in interpreting personal genomes and identifying pathogenic mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1003709

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A regression plot illustrating the regression of Y on X. The plot is annotated for the 2% extremes: red = 2% most intolerant, blue = 2% most tolerant. Five outlier genes with >140 common functional variant sites (y-axis) are not shown.
Figure 1 A regression plot illustrating the regression of Y on X. The plot is annotated for the 2% extremes: red = 2% most intolerant, blue = 2% most tolerant. Five outlier genes with >140 common functional variant sites (y-axis) are not shown.CC BY · PubMed Central
Figure 2 [A] Cumulative percentage plots for the residual variation intolerance scores among six OMIM lists. [B] ROC curves of the residual variation intolerance scores' capacity to predict the corresponding OMIM list.
Figure 2 [A] Cumulative percentage plots for the residual variation intolerance scores among six OMIM lists. [B] ROC curves of the residual variation intolerance scores' capacity to predict the corresponding OMIM list.CC BY · PubMed Central
Figure 3 ROC curves of the residual variation intolerance scores' capacity to predict the corresponding independent gene-list.
Figure 3 ROC curves of the residual variation intolerance scores' capacity to predict the corresponding independent gene-list.CC BY · PubMed Central
Figure 4 The proportion of genes explained by each of the 25-percentile bins (RVIS) for the human disease networks disorder class with the lowest “Developmental Disorders” and highest “Immunological Disorders” average residual variation intolerance score.
Figure 4 The proportion of genes explained by each of the 25-percentile bins (RVIS) for the human disease networks disorder class with the lowest “Developmental Disorders” and highest “Immunological Disorders” average residual variation intolerance score.CC BY · PubMed Central
Figure 5 The percentage of de novo mutations occurring in the most intolerant quartile (25th percentile) across the severe ID, autistic, epileptic encephalopathy, and control siblings, for the different variant effect types. LGD = Likely Gene Disrupting (including nonsense, coding indels, and splice acceptor/donor site mutations). *Taking the CCDS of RVIS genes, 38% reflects the total real estate occupied by the 25th percentile most intolerant genes. P-values reflect binomial exact tests where the probability of success is adjusted to 0.38, accounting for the gene sizes of the 25% most intolerant genes.
Figure 5 The percentage of de novo mutations occurring in the most intolerant quartile (25th percentile) across the severe ID, autistic, epileptic encephalopathy, and control siblings, for the different variant effect types. LGD = Likely Gene Disrupting (including nonsense, coding indels, and splice acceptor/donor site mutations). *Taking the CCDS of RVIS genes, 38% reflects the total real estate occupied by the 25th percentile most intolerant genes. P-values reflect binomial exact tests where the probability of success is adjusted to 0.38, accounting for the gene sizes of the 25% most intolerant genes.CC BY · PubMed Central
Figure 6 2D plots illustrating possible utility of RVIS in conjunction with a variant-level quantitative score (PolyPhen-2) across cohorts with proposed de novo mutation genetic architectures. Plots reflect the single most damaging de novo missense mutation in individuals with at least one de novo missense mutation: [A] Controls (n = 247); [B] Severe ID (n = 67); [C] Epileptic Encephalopathies (n = 134); [D] Autism Spectrum Disorders (n = 412). Full lists of missense de novo mutations in the “hot zone” are available in Dataset S3, including loss of function SNV mutations (not plotted).
Figure 6 2D plots illustrating possible utility of RVIS in conjunction with a variant-level quantitative score (PolyPhen-2) across cohorts with proposed de novo mutation genetic architectures. Plots reflect the single most damaging de novo missense mutation in individuals with at least one de novo missense mutation: [A] Controls (n = 247); [B] Severe ID (n = 67); [C] Epileptic Encephalopathies (n = 134); [D] Autism Spectrum Disorders (n = 412). Full lists of missense de novo mutations in the “hot zone” are available in Dataset S3, including loss of function SNV mutations (not plotted).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. 2013, De novo mutation in the classic epileptic encephalopathies, Nature

Cited by

See all 907

Metadata

Authors
Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., & Goldstein, D. B.
Affiliations
  • The Royal Melbourne Hospital (AU)
  • Duke University (US)
Corresponding author
  • Petrovski, Slavé
  • Goldstein, David B.
Venue
PLoS Genetics
Published
2013-08-22
Volume
9
Issue
8
Pages
e1003709
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W1964426200
Cited by
901
References
27
Citations by year
2026: 14 · 2025: 36 · 2024: 44 · 2023: 46 · 2022: 57 · 2021: 83 · 2020: 85 · 2019: 91 · 2018: 86 · 2017: 91 · 2016: 107 · 2015: 102 · 2014: 54 · 2013: 4
FWCI
58.46
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (1rc2hl103010-01)
  • Medical Research Council
  • National Health and Medical Research Council
  • National Heart, Lung, and Blood Institute (HL 102923, RC2HL102925, HL-102924, RC2HL102926, RC2HL102923, UC2HL102924, RC2HL-103010, UC2HL102925, HL 103010, UC2HL102923, UC2HL103010, RC2HL102924, UC2HL102926)
  • National Institute of Neurological Disorders and Stroke (U01NS077303, U01NS077364)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
functional genetic variation, Mendelian disease genes, pathogenic variants, exome sequencing, susceptibility genes, variant pathogenicity
MeSH terms
Humans, Mutation, Genetic Variation, Genome, Human, Genetic Diseases, Inborn, Precision Medicine, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes. https://app.cochat.ai/papers/10.1371/journal.pgen.1003709
The paper
Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., & Goldstein, D. B. (2013). Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1003709

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.